Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 23 studies | 24% ± 6% | |
naive B cell | 17 studies | 26% ± 7% | |
memory B cell | 16 studies | 22% ± 4% | |
classical monocyte | 4 studies | 20% ± 4% | |
epithelial cell | 4 studies | 37% ± 10% | |
ciliated cell | 4 studies | 25% ± 11% | |
immature B cell | 4 studies | 25% ± 6% | |
mast cell | 4 studies | 20% ± 3% | |
non-classical monocyte | 3 studies | 22% ± 6% | |
precursor B cell | 3 studies | 24% ± 2% | |
germinal center B cell | 3 studies | 31% ± 8% | |
basal cell | 3 studies | 28% ± 6% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1109.56 | 1445 / 1445 | 100% | 37.31 | 183 / 183 |
breast | 100% | 1465.52 | 459 / 459 | 100% | 115.85 | 1115 / 1118 |
lung | 100% | 1319.50 | 577 / 578 | 100% | 36.30 | 1151 / 1155 |
bladder | 100% | 783.81 | 21 / 21 | 98% | 32.98 | 496 / 504 |
stomach | 100% | 1076.59 | 359 / 359 | 98% | 30.05 | 281 / 286 |
intestine | 100% | 1153.80 | 966 / 966 | 98% | 28.92 | 515 / 527 |
pancreas | 99% | 575.47 | 325 / 328 | 98% | 29.37 | 175 / 178 |
thymus | 100% | 765.81 | 652 / 653 | 97% | 23.27 | 584 / 605 |
ovary | 99% | 568.18 | 179 / 180 | 97% | 31.21 | 415 / 430 |
uterus | 99% | 652.64 | 169 / 170 | 97% | 32.76 | 443 / 459 |
kidney | 100% | 1135.76 | 89 / 89 | 95% | 25.86 | 857 / 901 |
skin | 100% | 1634.79 | 1809 / 1809 | 93% | 37.07 | 440 / 472 |
prostate | 100% | 750.46 | 245 / 245 | 93% | 21.53 | 467 / 502 |
liver | 100% | 635.88 | 226 / 226 | 86% | 16.75 | 351 / 406 |
brain | 94% | 372.34 | 2490 / 2642 | 91% | 21.21 | 644 / 705 |
adrenal gland | 98% | 659.27 | 254 / 258 | 51% | 6.54 | 118 / 230 |
adipose | 100% | 1141.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 67.89 | 29 / 29 |
spleen | 100% | 1822.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.77 | 1 / 1 |
blood vessel | 100% | 957.65 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 557.17 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 497.57 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1402.88 | 860 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 13.49 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0007032 | Biological process | endosome organization |
GO_0031901 | Cellular component | early endosome membrane |
GO_0030133 | Cellular component | transport vesicle |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005769 | Cellular component | early endosome |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PLEKHF2 |
Protein name | Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2) (Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains) (EAPF) (PH and FYVE domain-containing protein 2) (Phafin-2) (Phafin2) (Zinc finger FYVE domain-containing protein 18) |
Synonyms | ZFYVE18 |
Description | FUNCTION: May play a role in early endosome fusion upstream of RAB5, hence regulating receptor trafficking and fluid-phase transport. Enhances cellular sensitivity to TNF-induced apoptosis . . |
Accessions | ENST00000315367.4 ENST00000700745.1 ENST00000700749.1 ENST00000700748.1 Q9H8W4 ENST00000519516.1 ENST00000700746.1 |